Total Payments
$43,031
2024 Payments
$590.83
Companies
19
Transactions
344
Medicare Patients
18,703
Medicare Billing
$2.1M
Payment Breakdown by Category
Other$21,500 (50.0%)
Food & Beverage$8,786 (20.4%)
Travel$6,523 (15.2%)
Consulting$6,210 (14.4%)
Education$12.50 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $21,500 | 6 | 50.0% |
| Food and Beverage | $8,786 | 289 | 20.4% |
| Travel and Lodging | $6,523 | 39 | 15.2% |
| Consulting Fee | $6,210 | 8 | 14.4% |
| Education | $12.50 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $29,584 | 168 | $0 (2024) |
| Abbott Laboratories | $4,817 | 38 | $0 (2024) |
| BIOTRONIK INC. | $3,913 | 22 | $0 (2019) |
| Medtronic, Inc. | $2,542 | 21 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $282.83 | 17 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $273.47 | 13 | $0 (2024) |
| Medtronic Vascular, Inc. | $270.24 | 5 | $0 (2020) |
| Impulse Dynamics (USA) Inc. | $262.72 | 10 | $0 (2022) |
| Amgen Inc. | $167.49 | 10 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $146.42 | 10 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $590.83 | 33 | Abbott Laboratories ($230.60) |
| 2023 | $2,945 | 47 | Medtronic, Inc. ($2,420) |
| 2022 | $1,029 | 49 | Boston Scientific Corporation ($297.41) |
| 2021 | $908.90 | 31 | Boston Scientific Corporation ($514.33) |
| 2020 | $438.65 | 21 | Boston Scientific Corporation ($208.29) |
| 2019 | $10,047 | 40 | Boston Scientific Corporation ($9,500) |
| 2018 | $10,248 | 61 | BOSTON SCIENTIFIC CORPORATION ($4,703) |
| 2017 | $16,824 | 62 | BOSTON SCIENTIFIC CORPORATION ($14,033) |
All Payment Transactions
344 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/26/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/26/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/26/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/26/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/26/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/09/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $19.00 | General |
| 11/27/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Genetic Disease | ||||||
| 11/26/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Genetic Disease | ||||||
| 10/01/2024 | Abbott Laboratories | ENSITE (Device) | Food and Beverage | In-kind items and services | $7.86 | General |
| Category: Electrophysiology | ||||||
| 09/27/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $57.17 | General |
| Category: LUX-Dx_CRM | ||||||
| 09/20/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Cardiac Rhythm Management | ||||||
| 09/03/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $19.00 | General |
| 08/20/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/13/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $5.68 | General |
| Category: Cardiac Rhythm Management | ||||||
| 07/16/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/07/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $1.74 | General |
| Category: Cardiac Rhythm Management | ||||||
| 05/23/2024 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $45.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/15/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Cardiac Rhythm Management | ||||||
| 05/09/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.10 | General |
| Category: Cardiovascular | ||||||
| 04/19/2024 | Medtronic, Inc. | PULSESELECT (Device) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Ablation | ||||||
| 04/08/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/28/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Cardiac Rhythm Management | ||||||
| 03/28/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $8.42 | General |
| Category: Cardiac Rhythm Management | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 38 | 4,713 | 7,805 | $1.5M | $535,686 |
| 2022 | 38 | 4,233 | 7,696 | $921,424 | $536,729 |
| 2021 | 44 | 4,924 | 8,245 | $933,653 | $541,786 |
| 2020 | 41 | 4,833 | 7,524 | $906,198 | $529,172 |
Total Patients
18,703
Total Services
31,270
Medicare Billing
$2.1M
Procedure Codes
165
All Medicare Procedures & Services
165 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 33285 | Insertion of heart rhythm monitor under skin | Office | 2023 | 22 | 22 | $237,892 | $86,535 | 36.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 386 | 471 | $186,026 | $65,470 | 35.2% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 543 | 1,486 | $148,600 | $48,755 | 32.8% |
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2023 | 45 | 46 | $110,170 | $36,596 | 33.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 137 | 137 | $66,105 | $23,491 | 35.5% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 52 | 52 | $58,645 | $22,019 | 37.5% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 687 | 1,090 | $54,640 | $21,797 | 39.9% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 354 | 1,010 | $57,126 | $21,225 | 37.2% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 498 | 775 | $50,127 | $19,273 | 38.4% |
| 33249 | Insertion of implantable defibrillator system | Facility | 2023 | 24 | 24 | $47,815 | $18,509 | 38.7% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 22 | 22 | $45,752 | $16,643 | 36.4% |
| 93653 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | Facility | 2023 | 22 | 22 | $39,267 | $15,382 | 39.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 140 | $39,315 | $14,000 | 35.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 73 | 75 | $31,580 | $10,870 | 34.4% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 156 | 165 | $30,644 | $10,829 | 35.3% |
| 33225 | Insertion of left lower heart electrode for pacemaker or defibrillator | Facility | 2023 | 27 | 27 | $27,103 | $10,472 | 38.6% |
| 33340 | Repair of left upper heart chamber with implant with review by radiologist | Facility | 2023 | 16 | 16 | $26,962 | $10,214 | 37.9% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 190 | 481 | $27,205 | $10,148 | 37.3% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 198 | 328 | $26,279 | $9,965 | 37.9% |
| 33274 | Insertion of permanent leadless pacemaker using imaging guidance | Facility | 2023 | 22 | 22 | $23,041 | $8,508 | 36.9% |
| 93657 | Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | Facility | 2023 | 12 | 30 | $19,982 | $7,721 | 38.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 488 | 619 | $21,759 | $6,925 | 31.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 42 | 52 | $11,315 | $5,212 | 46.1% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 45 | 49 | $11,950 | $4,185 | 35.0% |
| 33228 | Removal and replacement of dual lead permanent pacemaker | Facility | 2023 | 14 | 14 | $10,860 | $4,052 | 37.3% |
About Dr. Mark Mascarenhas, MD
Dr. Mark Mascarenhas, MD is a Cardiovascular Disease healthcare provider based in Eatontown, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/22/2008. The National Provider Identifier (NPI) number assigned to this provider is 1841477817.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Mascarenhas, MD has received a total of $43,031 in payments from pharmaceutical and medical device companies, with $590.83 received in 2024. These payments were reported across 344 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($21,500).
As a Medicare-enrolled provider, Mascarenhas has provided services to 18,703 Medicare beneficiaries, totaling 31,270 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 165 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Clinical Cardiac Electrophysiology
- Location Eatontown, NJ
- Active Since 01/22/2008
- Last Updated 01/17/2017
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1841477817
Products in Payments
- WATCHMAN (Device) $26,673
- Accent Pacemaker (Device) $2,960
- Siello (Device) $2,938
- RESONATE (Device) $1,282
- ICDs (Device) $312.00
- ELIQUIS (Drug) $311.94
- ACCOLADE (Device) $308.91
- Occluders (Device) $269.13
- Ensite Cardiac Mapping System (Device) $264.05
- ENTRESTO (Drug) $233.72
- AVEIR (Device) $222.74
- SQ-RX PULSE GENERATOR (Device) $208.29
- DYNAGEN (Device) $194.19
- Micra (Device) $181.34
- Optimizer Smart System (Device) $164.32
- RESONATE EL ICD VR (Device) $164.23
- WATCHMAN Access System (Device) $150.09
- XARELTO (Drug) $146.42
- ACCOLADE SR (Device) $137.21
- LUX-Dx Insertable Cardiac Monitor (Device) $131.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Eatontown
Dr. Brett Sealove, M.d, M.D
Cardiovascular Disease — Payments: $505,646
Cardiovascular Disease $505,646
Dr. Scott Eisenberg, Do, DO
Cardiovascular Disease — Payments: $228,853
Cardiovascular Disease $228,853
Dr. Eran Zacks, Md, MD
Cardiovascular Disease — Payments: $36,057
Cardiovascular Disease $36,057
Dr. Nelson Lamarche, M.d, M.D
Cardiovascular Disease — Payments: $16,389
Cardiovascular Disease $16,389
Dr. Ajay Shah, Md, Ms, Frcs, Dnb, MD, MS, FRCS, DNB
Cardiovascular Disease — Payments: $9,713
Cardiovascular Disease $9,713
Dr. Lynne Einbinder, M.d, M.D
Cardiovascular Disease — Payments: $9,203
Cardiovascular Disease $9,203